Pharmaceuticals, Biotechnology and Life Sciences
Funding Extends Company’s Cash Runway into Second Quarter 2025, which is beyond the Anticipated Timing for SHIELD II Top-line Results…
MALVERN, Pa., July 31, 2024 (GLOBE NEWSWIRE) — Ocugen, Inc. (Nasdaq: OCGN), a biotechnology company focused on discovering, developing, and…
Ryoncil BLA Submission Under FDA Review for Approval in Children with SR-aGVHDNEW YORK, July 30, 2024 (GLOBE NEWSWIRE) — Mesoblast…
Châtillon, France, July 30, 2024 DBV Technologies Announces Filing of 2024 Half-Year Report ― Conditions for Accessing or Consulting the…
DEER PARK, Ill., July 30, 2024 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc. (“Eton” or the “Company”) (Nasdaq: ETON), an innovative…
51% of No Tau / Low Tau Patients Showed Improved Cognition and Function Over Three Years; Only Lecanemab Has Clinical…
Expanding Capabilities and Streamlining Experimental WorkflowsFREMONT, Calif., July 30, 2024 (GLOBE NEWSWIRE) — Today Cytek Biosciences, Inc. (Nasdaq: CTKB) announced…
AUSTIN, TX and DURHAM, NC, July 30, 2024 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology…
TORONTO, July 30, 2024 (GLOBE NEWSWIRE) — Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF)…
SAN DIEGO, July 30, 2024 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (OTCQB: TCON) today announced that the Company has terminated its…